|1.||Robak, Tadeusz: 10 articles (12/2015 - 03/2002)|
|2.||Bielawski, Krzysztof: 6 articles (11/2011 - 08/2003)|
|3.||Bielawska, Anna: 6 articles (11/2011 - 08/2003)|
|4.||Stilgenbauer, Stephan: 5 articles (12/2015 - 10/2009)|
|5.||Goede, Valentin: 5 articles (06/2015 - 10/2009)|
|6.||Hallek, Michael: 5 articles (06/2015 - 10/2009)|
|7.||Leblanc, Valérie: 5 articles (06/2013 - 03/2010)|
|8.||Bérubé, Gervais: 5 articles (06/2013 - 03/2010)|
|9.||Catovsky, Daniel: 5 articles (01/2013 - 02/2008)|
|10.||Gottesfeld, Joel M: 5 articles (06/2012 - 11/2004)|
|1.||Nephrotic Syndrome (Syndrome, Nephrotic)
02/01/1978 - "The data indicate that a stable dosage regimen for chlorambucil is as effective as an increasing dose regimen in achieving long-term remission of frequently relapsing nephrotic syndrome."
01/01/1978 - "Controlled trial of chlorambucil in frequently relapsing nephrotic syndrome in children (a preliminary report)."
04/01/2006 - "Chlorambucil therapy in children with steroid-resistant nephrotic syndrome."
10/01/1992 - "Two men were treated for a nephrotic syndrome with high-dose chlorambucil therapy; 6.5 and 14 years later, respectively, both were azoospermic with high plasmatic FSH values. "
01/01/1991 - "We report the SCE of peripheral blood lymphocytes in children with primary nephrotic syndrome (NS) treated with chlorambucil. "
|2.||B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/01/1980 - "Forty patients with lymphocytic lymphoma were treated with escalating doses of chlorambucil biweekly starting at a dose of 0.4 mg/kg. Fifty percent of patients achieved a complete remission, usually after 6-12 months of therapy. "
02/01/2009 - "The overall remission rate was 59% in a prospective, randomized study of untreated patients with chronic lymphocytic leukemia, which was significantly greater than the rate of 26% in the chlorambucil control arm (P < 0.001). "
12/17/2015 - "Ibrutinib was superior to chlorambucil in previously untreated patients with CLL or small lymphocytic lymphoma, as assessed by progression-free survival, overall survival, response rate, and improvement in hematologic variables. "
09/01/2015 - "Its superiority in association with chlorambucil as compared with chlorambucil alone has led to its approval as a first-line treatment for chronic lymphocytic leukemia, for patients who are not candidates for a more intensive treatment. "
06/01/2014 - "Obinutuzumab is a novel therapeutic anti-CD20 monoclonal antibody recently approved by the United States Food and Drug Administration (FDA) for use in combination with chlorambucil as first-line treatment of chronic lymphocytic leukemia (CLL). "
|3.||Membranous Glomerulonephritis (Membranous Nephropathy)
11/01/1999 - "We conclude that steroid therapy alone, or associated with chlorambucil, is effective in patients with stage II to III membranous nephropathy. "
01/01/1983 - "Controlled trial of monthly alternated courses of steroid and chlorambucil for idiopathic membranous nephropathy."
01/01/2009 - "Efficacy and safety of low-dose chlorambucil in nephrotic patients with idiopathic membranous nephropathy."
01/01/2001 - "Severe bone marrow failure associated with the use of alternating steroid with chlorambucil in lupus membranous nephropathy in Chinese."
06/01/1996 - "Complete remission of nephrotic syndrome after steroid-chlorambucil in a previous failed short-term steroidal treatment of a primary membranous nephropathy."
11/11/2000 - "Clinical efficacy of alkylating anticancer drugs, such as chlorambucil, is often limited by the emergence of drug resistant tumor cells. "
11/20/2013 - "In vitro biological studies reveal acridin-9-methanol nanoparticles of ~60 nm size to be very efficient in delivering the anticancer drug chlorambucil into the target nucleus, killing the cancer cells upon irradiation. "
06/01/2012 - "The purpose of this study was to assess the toxicoses and antitumor activity of metronomic chlorambucil at a dosage of 4 mg m(-2) daily in dogs with naturally occurring cancer. "
08/09/2004 - "An anti-cancer drug (chlorambucil, CLB), which can form an inclusion complex with beta-CD, was selected for loading and in vitro release studies. "
12/01/2000 - "A morphological study of the effect of chlorambucil during the S and G2 phases of the cell cycle of synchronized HEp-2 cancer cell populations using computerized morphometry."
01/01/2013 - "This is the first documented report of the efficacy of oral chlorambucil in the treatment of primary uveal lymphoma."
02/01/2004 - "In the treatment of lymphoma, single agent chlorambucil does not confer a durable remission. "
11/15/1984 - "The clonal B-cell expansion was brought into a lasting remission by chlorambucil, but the cutaneous lymphoma proved to be refractory to therapy. "
04/01/2002 - "The International Extranodal Lymphoma Study Group, the United Kingdom Lymphoma Group, and the Groupe d'Etude des Lymphomes de l'Adulte have conducted a trial to ascertain whether the addition of chlorambucil is of benefit after anti-H pylori therapy. "
11/12/1955 - "Clinical trials of p-(di-2-chloroethylamino)-phenylbutyric acid (CB 1348) in malignant lymphoma."
|9.||Vinblastine (Vinblastine Sulfate)
|1.||Drug Therapy (Chemotherapy)
|2.||Combination Drug Therapy (Combination Chemotherapy)